Antibiotics Pediatric dosing.pdf

Rahul Verma
Rahul VermaPaediatric Registrar à Choithram Hospital & Research Centre, Indore (M.P.)
LPCHS Formulary Antimicrobials
 The doses provided are general recommendations
and do NOT include neonatal dosing, cystic fibrosis
dosing, or renal dose adjustment.
 Please refer to the Housestaff Manual or Neofax
for additional recommendations and indication-
specific dosing.
 Maximum individual doses in parentheses.
 Renal dose adjustment parameters indicated by
superscript:
1
Adjustment needed if CrCl < 70 mL/min
2
Adjustment needed if CrCl < 50 mL/min
3
Adjustment needed if CrCl < 30 mL/min
 All inpatient restricted antimicrobial use, including
continuation of home medications, requires Pedi-
atric Infectious Disease (ID) approval. Contact the
Pediatric ID fellow on-call for approval.
 For additional assistance, consider ASP or ID
consultation.
(ID) = Requires ID approval for use:
Colistin Linezolid Posaconazole
Cidofovir Micafungin Tigecycline
Daptomycin
(PI) = Prolonged infusion may be considered (i.e.,
extended infusion, continuous infusion)
(R) = Restricted indications (requires ID approval)
(TDM) = Therapeutic drug monitoring recommended
GENERAL INFORMATION
ABBREVIATIONS
THERAPEUTIC DRUG MONITORING
DRUG
DOSING
INTERVAL
TROUGH
(mcg/mL)
PEAK*
(mcg/mL)
Amikacin
Q8h
< 8
20—30
Q24h 30—55
Gentamicin
or
Tobramycin
Q8h
< 1
4—10
Q24h 15—25
Posaconazole Variable
Prophylaxis
>700 ng/mL
Treatment
>1250 ng/mL
N/A
Vancomycin
Usual
dosing
10—20 N/A
Voriconazole Q12h 1—6 N/A
*30min post end of 30 min infusion or 60 min post end of 60min infusion
PARENTERAL (IV) ANTIBIOTICS
DRUG DOSAGE
Amikacin2
(TDM)
7.5 mg/kg/dose q8h (500 mg)
15—20 mg/kg/dose q24h (1.5 g)
CF: 30 mg/kg/dose q24h
Ampicillin3
50—100 mg/kg/dose q6h (2g)
Ampicillin/
sulbactam3
50 mg/kg/dose q6h (2g) (dose based on
ampicillin)
Aztreonam3
30 mg/kg/dose q6h (2g)
CF: 50 mg/kg/dose q6h (2g)
Cefazolin3
16.5—50 mg/kg/dose q8h (2g)
Cefepime2
(PI) 50 mg/kg/dose q8h (2g)
Cefoxitin 40 mg/kg/dose q6-8h (2g)
Ceftazidime2
(PI)
50 mg/kg/dose q8h (2g)
Ceftriaxone 50—75 mg/kg/dose q24h (2g)
Meningitis: 50 mg/kg/dose q12h (2g)
Ciprofloxacin3
10—15 mg/kg/dose q8-12h (400mg)
Clindamycin 10—13 mg/kg/dose q8h (900mg)
Colistin (ID)1
1.7—2.5 mg/kg/dose q8-12h
Daptomycin3
(ID)
6—12 mg/kg/dose q24h
Doxycycline 2 mg/kg/dose q12h (100mg)
Gentamicin2
(TDM)
2—2.5 mg/kg/dose q8h
5—7.5 mg/kg/dose q24h
Synergy: 1—3 mg/kg/dose q8-24h
Levofloxacin2
<5yr: 8—10 mg/kg/dose q12h
>5yr: 10 mg/kg/dose q24h (750mg)
Linezolid (ID) <12yr: 10 mg/kg/dose q8h (600mg)
>12 yr: 10 mg/kg/dose q12h
(600mg)
Meropenem2
(PI)
20 mg/kg/dose q8h (1g)
Meningitis/CF: 40 mg/kg/dose q8h
(2g)
Metronida-
zole3
10 mg/kg/dose q8h (750mg)
Appendicitis: 30 mg/kg/dose q24h
(1g, unless >80kg, then 1.5g)
Nafcillin3
(PI) 33-50 mg/kg/dose q4-6h (2g)
Penicillin G3
25,000—66,000 units/kg/dose q4-6h
(4million units)
Piperacillin/
tazobactam2
(PI)
80—100 mg/kg/dose q6-8h (4g)
Tigecycline
(ID)
<40kg: 1.2 mg/kg/dose q12h(50mg)
>40kg: Load 1.2 mg/kg/dose (100
mg), followed by 50 mg q12h
Tobramycin2
2—2.5 mg/kg/dose q8h
5—7.5 mg/kg/dose q24h
Trimethoprim/
sulfamethoxa-
zole
3
(dose based
on trimethoprim)
Treatment: 3-6 mg/kg/dose q12h
(160mg)
Stenotrophomonas: 5 mg/kg/dose
q8h (320mg)
PCP: 5 mg/kg/dose q6-8h (320mg)
Vancomycin3
(TDM)
15—20 mg/kg/dose q6-8h (per
Pharmacy)
ENTERAL (PO) ANTIBIOTICS
Amoxicillin3
12.5—30 mg/kg/dose TID (1g)
S. pneumoniae: 40—45 mg/kg/dose
BID (2g)
Amoxicillin/
clavulanate3
12.5—30 mg/kg/dose TID (875mg)
S. pneumoniae: 40—45 mg/kg/dose
BID (2g) (dose based on amoxicillin)
Azithromycin Respiratory infection: 10 mg/kg
once on day 1 (500mg), then 5 mg/
kg (250mg) q24h on days 2-5
Cefdinir3
7 –14 mg/kg/dose daily—BID
(600mg/day)
Cefixime1
(R) 8 mg/kg/dose once daily (400mg)
Cefuroxime3
15 mg/kg/dose BID (500mg)
Cephalexin3
12.5—50 mg/kg/dose TID-QID (1g)
Ciprofloxacin3
10—15 mg/kg/dose BID (750mg)
Clindamycin3
7—10 mg/kg/dose TID (600mg)
Doxycycline 2 mg/kg/dose q12h (100mg)
Levofloxacin2
<5yr: 8—10 mg/kg/dose q12h
>5yr: 10 mg/kg/dose q24h (750mg)
Linezolid (ID) <12yr: 10 mg/kg/dose q8h (600mg)
>12yr:10 mg/kg/dose q12h (600mg)
Metronidazole 10 mg/kg/dose q8h (750mg)
Nitro-
furantoin1
(Macrodantin
®)
Treatment: 1.2—2.5 mg/kg/dose
QID (100mg)
Prophylaxis: 1—2 mg/kg/dose
daily—BID (100mg)
Penicillin3
12.5 mg/kg/dose QID (500mg)
Rifampin 5-10 mg/kg/dose daily-BID (600mg)
Trime-
thoprim /
sulfamethoxa-
zole3
Treatment: 3-6 mg TMP compo-
nent/kg/dose q12h (160mg)
Prophylaxis: 2-5mg TMP compo-
nent/kg/dose daily (160mg)
ANTIFUNGALS
Liposomal
amphotericin
IV: 3—5 mg/kg/dose q24h
Caspofungin Treatment: IV: Load 70 mg/m2
once
(70mg), then 50 mg/m2
daily (50mg)
Prophylaxis: IV: 1 mg/kg/dose q24h
(50mg)
Micafungin
(ID)
Treatment: IV: 2—4 mg/kg/dose q24h
(150mg)
Prophylaxis: IV: 1.5 mg/kg/dose q24h
(50mg)
Fluconazole2
IV/PO: Loading dose 6—12 mg/kg/
dose once, followed by 3– 12 mg/kg/
dose daily (800mg)
Posaconazole
(ID) (TDM)
Treatment (suspension): 5.5 mg/kg/
dose QID (200mg)
Prophylaxis (suspension): 4 mg/kg/
dose TID (200mg)
Treatment/Prophylaxis (tablet): 300mg
BID X 1 day, then 300mg once daily
Voriconazole
(TDM)
See age-specific HSM recommendation
Treatment: IV/PO: 6—9 mg/kg/dose
q12h x 2 doses, followed by 4—9 mg/
kg/dose q12h
Prophylaxis: IV/PO: 7 mg/kg/dose BID
(200mg)
ANTIVIRALS
Acyclovir2
>70kg: Use ideal body weight
Treatment: IV: 10—15 mg/kg/dose
q8h (800mg); PO:15—20 mg/kg/dose 3
-5x/day (800mg); hydration required
Prophylaxis: IV: 5 mg/kg/dose or 250
mg/m2
q8h (300mg); PO: 10—15 mg/
kg/dose TID (300mg)
Cidofovir (ID) 1—5 mg/kg/dose IV 1-3 x/week
(hydration required; +/- probenecid)
Ganciclovir1
Treatment: 5 mg/kg/dose IV q12h
Prophylaxis: 5 mg/kg/dose IV q24h
Oseltamivir3
(PO)
Treatment: 3 mg/kg/dose BID (75 mg)
Prophylaxis: 3 mg/kg/dose daily
(75mg)
Valacyclovir2
Treatment: 20 mg/kg/dose PO BID (1g)
Prophylaxis: 250—500 mg PO BID
Valgan-
ciclovir1
Treatment: 12—20 mg/kg/dose IV
q12h (900 mg)
Prophylaxis: 10—15 mg/kg/dose IV
daily (900mg)
1 sur 1

Recommandé

Gastric carcinoma treatment par
Gastric carcinoma   treatment Gastric carcinoma   treatment
Gastric carcinoma treatment Preethiya Seenivasan
86 vues28 diapositives
antibiotics induced renal failure par
antibiotics induced renal failureantibiotics induced renal failure
antibiotics induced renal failureManoj Choudhary
2K vues39 diapositives
PediRefCard.pdf par
PediRefCard.pdfPediRefCard.pdf
PediRefCard.pdfMuhammadAbbasWali
137 vues2 diapositives
management of SLE.pptx par
management of SLE.pptxmanagement of SLE.pptx
management of SLE.pptxShah Prakashman
7 vues41 diapositives
Leukemia case answer par
Leukemia case answerLeukemia case answer
Leukemia case answerABDULLAHALHAJI2
341 vues46 diapositives
Presentasi Kasus Bidang Geriatri (Pharmaceutical Geriatric) par
Presentasi Kasus Bidang Geriatri (Pharmaceutical Geriatric)Presentasi Kasus Bidang Geriatri (Pharmaceutical Geriatric)
Presentasi Kasus Bidang Geriatri (Pharmaceutical Geriatric)Gilang Rizki
91 vues17 diapositives

Contenu connexe

Similaire à Antibiotics Pediatric dosing.pdf

Arrhythmias par
Arrhythmias Arrhythmias
Arrhythmias Raniya Khalid
15 vues11 diapositives
Anti platelet therapy par
Anti platelet therapyAnti platelet therapy
Anti platelet therapyBALASUBRAMANIAM IYER
4.9K vues44 diapositives
263_Dosing-information-in-renal-impairment.pdf par
263_Dosing-information-in-renal-impairment.pdf263_Dosing-information-in-renal-impairment.pdf
263_Dosing-information-in-renal-impairment.pdfTAWFIKABBAD
1 vue18 diapositives
Rheumatoid arthritis management par
Rheumatoid arthritis management Rheumatoid arthritis management
Rheumatoid arthritis management Praveen Nagula
7.1K vues83 diapositives
DIRECT THROMBIN INHIBITORS.pptx par
DIRECT THROMBIN INHIBITORS.pptxDIRECT THROMBIN INHIBITORS.pptx
DIRECT THROMBIN INHIBITORS.pptxNOM KUMAR NAIK BHUKYA
21 vues33 diapositives
DIAGNOSIS AND MANAGEMENT OF MALARIA par
DIAGNOSIS AND MANAGEMENT OF MALARIADIAGNOSIS AND MANAGEMENT OF MALARIA
DIAGNOSIS AND MANAGEMENT OF MALARIANisheeth Patel
25.1K vues46 diapositives

Similaire à Antibiotics Pediatric dosing.pdf(20)

263_Dosing-information-in-renal-impairment.pdf par TAWFIKABBAD
263_Dosing-information-in-renal-impairment.pdf263_Dosing-information-in-renal-impairment.pdf
263_Dosing-information-in-renal-impairment.pdf
TAWFIKABBAD1 vue
Rheumatoid arthritis management par Praveen Nagula
Rheumatoid arthritis management Rheumatoid arthritis management
Rheumatoid arthritis management
Praveen Nagula7.1K vues
DIAGNOSIS AND MANAGEMENT OF MALARIA par Nisheeth Patel
DIAGNOSIS AND MANAGEMENT OF MALARIADIAGNOSIS AND MANAGEMENT OF MALARIA
DIAGNOSIS AND MANAGEMENT OF MALARIA
Nisheeth Patel25.1K vues
Immune Thrombocytopenia Purpura par spa718
Immune Thrombocytopenia PurpuraImmune Thrombocytopenia Purpura
Immune Thrombocytopenia Purpura
spa7181.7K vues
Intravenous Drug Preparation and Administration EMTS Johore (1).pdf par azhaabaz
Intravenous Drug Preparation and Administration  EMTS Johore (1).pdfIntravenous Drug Preparation and Administration  EMTS Johore (1).pdf
Intravenous Drug Preparation and Administration EMTS Johore (1).pdf
azhaabaz267 vues
Nephrotic syndrome IN CHILDREN Lecture for MBBS par Sajjad Sabir
Nephrotic syndrome IN CHILDREN  Lecture for MBBSNephrotic syndrome IN CHILDREN  Lecture for MBBS
Nephrotic syndrome IN CHILDREN Lecture for MBBS
Sajjad Sabir8.1K vues
Anti -Malarials - perspective and Treatment regimen par Muthuselvan Kamaraj
Anti -Malarials - perspective and Treatment regimen  Anti -Malarials - perspective and Treatment regimen
Anti -Malarials - perspective and Treatment regimen
Metoclopramide hydrochloride 10 mg tablets smpc taj pharmaceuticals par Taj Pharma
Metoclopramide hydrochloride 10 mg tablets smpc  taj pharmaceuticalsMetoclopramide hydrochloride 10 mg tablets smpc  taj pharmaceuticals
Metoclopramide hydrochloride 10 mg tablets smpc taj pharmaceuticals
Taj Pharma251 vues
Febuxostat for treatment of chronic gout par Choying Chen
Febuxostat for treatment of chronic goutFebuxostat for treatment of chronic gout
Febuxostat for treatment of chronic gout
Choying Chen5.4K vues
mTOR inhibitor in cancer par seayat1103
mTOR inhibitor in cancermTOR inhibitor in cancer
mTOR inhibitor in cancer
seayat11035.9K vues

Dernier

MENSTRUAL CYCLE.pdf par
MENSTRUAL CYCLE.pdfMENSTRUAL CYCLE.pdf
MENSTRUAL CYCLE.pdfRutvikunvar Raualji (PT)
18 vues24 diapositives
CMC(CHEMISTRY,MANUFACTURING AND CONTROL).pptx par
CMC(CHEMISTRY,MANUFACTURING AND CONTROL).pptxCMC(CHEMISTRY,MANUFACTURING AND CONTROL).pptx
CMC(CHEMISTRY,MANUFACTURING AND CONTROL).pptxJubinNath2
9 vues12 diapositives
Small Intestine.pptx par
Small Intestine.pptxSmall Intestine.pptx
Small Intestine.pptxMathew Joseph
230 vues50 diapositives
OVARIES.pdf par
OVARIES.pdfOVARIES.pdf
OVARIES.pdfRutvikunvar Raualji (PT)
14 vues15 diapositives
Examining Pleural Fluid.pptx par
Examining Pleural Fluid.pptxExamining Pleural Fluid.pptx
Examining Pleural Fluid.pptxFareeha Riaz
21 vues18 diapositives
Case Study_ AI in the Life Sciences Industry.pptx par
Case Study_ AI in the Life Sciences Industry.pptxCase Study_ AI in the Life Sciences Industry.pptx
Case Study_ AI in the Life Sciences Industry.pptxEmily Kunka, MS, CCRP
36 vues17 diapositives

Dernier(20)

CMC(CHEMISTRY,MANUFACTURING AND CONTROL).pptx par JubinNath2
CMC(CHEMISTRY,MANUFACTURING AND CONTROL).pptxCMC(CHEMISTRY,MANUFACTURING AND CONTROL).pptx
CMC(CHEMISTRY,MANUFACTURING AND CONTROL).pptx
JubinNath29 vues
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler) par The Swiss Pharmacy
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler) Asthalin Inhaler (Generic Albuterol Sulfate Inhaler)
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler)
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx par ABG
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptxINTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx
ABG115 vues
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl... par DipeshGamare
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...
DipeshGamare15 vues
The Art of naming drugs.pptx par DanaKarem1
The Art of naming drugs.pptxThe Art of naming drugs.pptx
The Art of naming drugs.pptx
DanaKarem116 vues
Biomedicine & Pharmacotherapy par Trustlife
Biomedicine & PharmacotherapyBiomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy
Trustlife199 vues
Cholera Romy W. (3).pptx par rweth613
Cholera Romy W. (3).pptxCholera Romy W. (3).pptx
Cholera Romy W. (3).pptx
rweth61365 vues

Antibiotics Pediatric dosing.pdf

  • 1. LPCHS Formulary Antimicrobials  The doses provided are general recommendations and do NOT include neonatal dosing, cystic fibrosis dosing, or renal dose adjustment.  Please refer to the Housestaff Manual or Neofax for additional recommendations and indication- specific dosing.  Maximum individual doses in parentheses.  Renal dose adjustment parameters indicated by superscript: 1 Adjustment needed if CrCl < 70 mL/min 2 Adjustment needed if CrCl < 50 mL/min 3 Adjustment needed if CrCl < 30 mL/min  All inpatient restricted antimicrobial use, including continuation of home medications, requires Pedi- atric Infectious Disease (ID) approval. Contact the Pediatric ID fellow on-call for approval.  For additional assistance, consider ASP or ID consultation. (ID) = Requires ID approval for use: Colistin Linezolid Posaconazole Cidofovir Micafungin Tigecycline Daptomycin (PI) = Prolonged infusion may be considered (i.e., extended infusion, continuous infusion) (R) = Restricted indications (requires ID approval) (TDM) = Therapeutic drug monitoring recommended GENERAL INFORMATION ABBREVIATIONS THERAPEUTIC DRUG MONITORING DRUG DOSING INTERVAL TROUGH (mcg/mL) PEAK* (mcg/mL) Amikacin Q8h < 8 20—30 Q24h 30—55 Gentamicin or Tobramycin Q8h < 1 4—10 Q24h 15—25 Posaconazole Variable Prophylaxis >700 ng/mL Treatment >1250 ng/mL N/A Vancomycin Usual dosing 10—20 N/A Voriconazole Q12h 1—6 N/A *30min post end of 30 min infusion or 60 min post end of 60min infusion PARENTERAL (IV) ANTIBIOTICS DRUG DOSAGE Amikacin2 (TDM) 7.5 mg/kg/dose q8h (500 mg) 15—20 mg/kg/dose q24h (1.5 g) CF: 30 mg/kg/dose q24h Ampicillin3 50—100 mg/kg/dose q6h (2g) Ampicillin/ sulbactam3 50 mg/kg/dose q6h (2g) (dose based on ampicillin) Aztreonam3 30 mg/kg/dose q6h (2g) CF: 50 mg/kg/dose q6h (2g) Cefazolin3 16.5—50 mg/kg/dose q8h (2g) Cefepime2 (PI) 50 mg/kg/dose q8h (2g) Cefoxitin 40 mg/kg/dose q6-8h (2g) Ceftazidime2 (PI) 50 mg/kg/dose q8h (2g) Ceftriaxone 50—75 mg/kg/dose q24h (2g) Meningitis: 50 mg/kg/dose q12h (2g) Ciprofloxacin3 10—15 mg/kg/dose q8-12h (400mg) Clindamycin 10—13 mg/kg/dose q8h (900mg) Colistin (ID)1 1.7—2.5 mg/kg/dose q8-12h Daptomycin3 (ID) 6—12 mg/kg/dose q24h Doxycycline 2 mg/kg/dose q12h (100mg) Gentamicin2 (TDM) 2—2.5 mg/kg/dose q8h 5—7.5 mg/kg/dose q24h Synergy: 1—3 mg/kg/dose q8-24h Levofloxacin2 <5yr: 8—10 mg/kg/dose q12h >5yr: 10 mg/kg/dose q24h (750mg) Linezolid (ID) <12yr: 10 mg/kg/dose q8h (600mg) >12 yr: 10 mg/kg/dose q12h (600mg) Meropenem2 (PI) 20 mg/kg/dose q8h (1g) Meningitis/CF: 40 mg/kg/dose q8h (2g) Metronida- zole3 10 mg/kg/dose q8h (750mg) Appendicitis: 30 mg/kg/dose q24h (1g, unless >80kg, then 1.5g) Nafcillin3 (PI) 33-50 mg/kg/dose q4-6h (2g) Penicillin G3 25,000—66,000 units/kg/dose q4-6h (4million units) Piperacillin/ tazobactam2 (PI) 80—100 mg/kg/dose q6-8h (4g) Tigecycline (ID) <40kg: 1.2 mg/kg/dose q12h(50mg) >40kg: Load 1.2 mg/kg/dose (100 mg), followed by 50 mg q12h Tobramycin2 2—2.5 mg/kg/dose q8h 5—7.5 mg/kg/dose q24h Trimethoprim/ sulfamethoxa- zole 3 (dose based on trimethoprim) Treatment: 3-6 mg/kg/dose q12h (160mg) Stenotrophomonas: 5 mg/kg/dose q8h (320mg) PCP: 5 mg/kg/dose q6-8h (320mg) Vancomycin3 (TDM) 15—20 mg/kg/dose q6-8h (per Pharmacy) ENTERAL (PO) ANTIBIOTICS Amoxicillin3 12.5—30 mg/kg/dose TID (1g) S. pneumoniae: 40—45 mg/kg/dose BID (2g) Amoxicillin/ clavulanate3 12.5—30 mg/kg/dose TID (875mg) S. pneumoniae: 40—45 mg/kg/dose BID (2g) (dose based on amoxicillin) Azithromycin Respiratory infection: 10 mg/kg once on day 1 (500mg), then 5 mg/ kg (250mg) q24h on days 2-5 Cefdinir3 7 –14 mg/kg/dose daily—BID (600mg/day) Cefixime1 (R) 8 mg/kg/dose once daily (400mg) Cefuroxime3 15 mg/kg/dose BID (500mg) Cephalexin3 12.5—50 mg/kg/dose TID-QID (1g) Ciprofloxacin3 10—15 mg/kg/dose BID (750mg) Clindamycin3 7—10 mg/kg/dose TID (600mg) Doxycycline 2 mg/kg/dose q12h (100mg) Levofloxacin2 <5yr: 8—10 mg/kg/dose q12h >5yr: 10 mg/kg/dose q24h (750mg) Linezolid (ID) <12yr: 10 mg/kg/dose q8h (600mg) >12yr:10 mg/kg/dose q12h (600mg) Metronidazole 10 mg/kg/dose q8h (750mg) Nitro- furantoin1 (Macrodantin ®) Treatment: 1.2—2.5 mg/kg/dose QID (100mg) Prophylaxis: 1—2 mg/kg/dose daily—BID (100mg) Penicillin3 12.5 mg/kg/dose QID (500mg) Rifampin 5-10 mg/kg/dose daily-BID (600mg) Trime- thoprim / sulfamethoxa- zole3 Treatment: 3-6 mg TMP compo- nent/kg/dose q12h (160mg) Prophylaxis: 2-5mg TMP compo- nent/kg/dose daily (160mg) ANTIFUNGALS Liposomal amphotericin IV: 3—5 mg/kg/dose q24h Caspofungin Treatment: IV: Load 70 mg/m2 once (70mg), then 50 mg/m2 daily (50mg) Prophylaxis: IV: 1 mg/kg/dose q24h (50mg) Micafungin (ID) Treatment: IV: 2—4 mg/kg/dose q24h (150mg) Prophylaxis: IV: 1.5 mg/kg/dose q24h (50mg) Fluconazole2 IV/PO: Loading dose 6—12 mg/kg/ dose once, followed by 3– 12 mg/kg/ dose daily (800mg) Posaconazole (ID) (TDM) Treatment (suspension): 5.5 mg/kg/ dose QID (200mg) Prophylaxis (suspension): 4 mg/kg/ dose TID (200mg) Treatment/Prophylaxis (tablet): 300mg BID X 1 day, then 300mg once daily Voriconazole (TDM) See age-specific HSM recommendation Treatment: IV/PO: 6—9 mg/kg/dose q12h x 2 doses, followed by 4—9 mg/ kg/dose q12h Prophylaxis: IV/PO: 7 mg/kg/dose BID (200mg) ANTIVIRALS Acyclovir2 >70kg: Use ideal body weight Treatment: IV: 10—15 mg/kg/dose q8h (800mg); PO:15—20 mg/kg/dose 3 -5x/day (800mg); hydration required Prophylaxis: IV: 5 mg/kg/dose or 250 mg/m2 q8h (300mg); PO: 10—15 mg/ kg/dose TID (300mg) Cidofovir (ID) 1—5 mg/kg/dose IV 1-3 x/week (hydration required; +/- probenecid) Ganciclovir1 Treatment: 5 mg/kg/dose IV q12h Prophylaxis: 5 mg/kg/dose IV q24h Oseltamivir3 (PO) Treatment: 3 mg/kg/dose BID (75 mg) Prophylaxis: 3 mg/kg/dose daily (75mg) Valacyclovir2 Treatment: 20 mg/kg/dose PO BID (1g) Prophylaxis: 250—500 mg PO BID Valgan- ciclovir1 Treatment: 12—20 mg/kg/dose IV q12h (900 mg) Prophylaxis: 10—15 mg/kg/dose IV daily (900mg)